In contrast, SUV420H2 mRNA levels did not differ significantly in either the breast cancer cells or clinical specimens (Fig. 3c–i), which is in accordance with a post-transcriptional mechanism that is involved in the regulation of SUV420H2. The gene discussed is KMT5C; the disease is breast cancer.